Onkologie. 2014:8(6):279-286

Other neoplasms among Czech survivors with bronchopulmonal cancer

Edvard Geryk1, Teodor Horváth2, Radim Štampach3, Petr Kubíček3
1 Odbor vědy a výzkumu, Fakutní nemocnice Brno

The neoplasms following primary lung cancer (LC) and primary neoplasms before LC analyzed a retrospective study in survivors, notified

in the National Czech Cancer Registry between 1976 and 2010. A total 16 622 LC in males associated with other neoplasms, presented

10 % of 166 239 newly registered LC in males, of which were 4,395 (2.6 %) primary and 12,227 (7.4 %) subsequent LC; a total 5,322 LC in

females, presented 14.1 % of 37,619 newly registered LC in females, of which were 1,022 (2.7 %) primary and 4,300 (11.4 %) subsequent

LC. The average interval of occurrence of subsequent neoplasms was 4.1 years in males and 3.9 years in females. Among subsequent

neoplasms (after LC) were about 23 % cancers of digestive and 14% urinary tract, in males 14% cancers of respiratory tract, 14 % skin and

11 % prostate, in females 11% cancers of female genital organs, 11 % skin and 11% breast. Among primary neoplasms (before LC) were

about 38 % cancers of skin, 13 % urinary, 13 % digestive and 10 % respiratory tract in males; 27 % cancers of skin, 21 % female genital organs,

17% breast, 9 % digestive and 5 % urinary tract in females. The yearly number of primary LC has increased since 1976 to 2010 from

65 to 119 cases, their representation at the early clinical stages decreased in 5-year periods from 53% to 22 %, at the advanced stages

increased from 20 % to 64 %; the number of subsequent LC increased from 23 to 1089 cases, their early clinical stages decreased from

33 % to 20 %, the advanced stages increased from 29 % to 63 %. The higher proportion of LC at the unknown stages limited detailed

analysis. In our study were estimated about 1,155 neoplasms at the advanced stages (19 % in males and 22 % in females of all subsequent

neoplasms) diagnosed after primary LC, which presented a monthly average of three cancers during 34 years. The most frequented

advanced stages of 4,966 selected subsequent cancers were cancers of ovary (47 %), other lung (males 45 %, females 52 %), larynx (males

45 %, females 52 %), oral cavity (males 41 %, females 39 %), stomach (males 28 %, females 42%), colorectum (males 33%, females 37 %),

cervix uteri (28 %), breast (25 %) and pancreas (males 23 %, females 26 %). Mainly subsequent advanced stages must be prevented by the

follow-up guidelines and early interventions. Limited resources and continuing risks of lifestyle including smoking do not allow to slow

down the increase of primary and subsequent neoplasms in the near future among cancer survivors not in pneumology.

Keywords: lung cancer, cancer multiplicity, primary and subsequent neoplasms, time-space-age distribution, clinical stages

Published: December 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Horváth T, Štampach R, Kubíček P. Other neoplasms among Czech survivors with bronchopulmonal cancer. Onkologie. 2014;8(6):279-286.
Download citation

References

  1. IARC. Globocan 2012. Lyon: IARC, Asssessed 10 July 2014; www.globocan.iarc.fr/pages/burden_sel.aspx.
  2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. Go to original source... Go to PubMed...
  3. DevCan. Probability of developing or dying of cancer software, Version 6.6.1. Statistical research and applications branch, National Cancer Institute, 2012. www.srab.cancer.gov/devcan.
  4. American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society, 2013: 14-17.
  5. ÚZIS. Novotvary ČR. Zdravotnická statistika, Praha: ÚZIS ČR, ediční řada 1976-2010, www.uzis.cz.
  6. ÚZIS. Hospitalizovaní v nemocnicích ČR 2012. Zdravotnická statistika, Praha: ÚZIS ČR, 2013: 27-67.
  7. Billroth T, von Winiwarter A. Die allgemeine chirurgische patologie und therapie. Berlin: G. Reimer, 1889: 1-971.
  8. Boice JD Jr, Fraumeni JF Jr. Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. Natl Cancer Inst Monogr, 1985; 68: 83-98. Go to PubMed...
  9. Levi F, Randimbison L, Te VC, et al. Second primary cancers in patients with lung carcinoma. Cancer 1999; 86(1): 186-190. Go to original source... Go to PubMed...
  10. Sagman U, Lishner M, Maki E, et al. Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol 1992; 10(10): 1525-1533. Go to original source... Go to PubMed...
  11. Pedersen-Bjergaard J, Osterlind K, Hansen M, et al. Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung. Blood 1985; 66(6): 1393-1397. Go to original source...
  12. Cote ML, Wenzlaff AS, Philip PA, et al. Secondary cancers after a lung carcinoid primary: a population-based analysis. Lung Cancer. 2006; 52(3): 273-279. Go to original source... Go to PubMed...
  13. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90(18): 1335-1345. Go to original source... Go to PubMed...
  14. Salminen E, Pukkala E, Teppo L, et al. Risk of second cancers among lung cancer patients. Acta Oncol 1995; 34, 2, 165-169. Go to original source... Go to PubMed...
  15. Caporaso NE, Dodd KW, Tucker MA. New malignancies following cancer of the respiratory tract. In: Curtis RE, et al. (eds). New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, NIH Publ. No. 05-5302. Bethesda, MD, 2006.
  16. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 1997; 89(23): 1782-1788. Go to original source... Go to PubMed...
  17. Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993; 119(5): 383-390. Go to original source... Go to PubMed...
  18. Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003; 14(2): 131-138. Go to original source... Go to PubMed...
  19. Geryk E, Štampach, R, Kubíček P, kol. Další novotvary u přežívajících s nemelanomovými nádory kůže. Dermatologie pro praxi, 2014; 8: v tisku.
  20. UZIS. Dohoda o předání anonymizovaných dat z NZIS. ÚZIS ČR a FN Brno, č.j. 429/13/La, 20.3. 2013.
  21. Horváth T, Geryk E, Kozel, J, kol. Rakovina plic ve vícečetných malignitách. Stud. Pneumol. Phthiseol. 2013; 73(3): 109-116.
  22. Dite P, Geryk E. Trends of primary and subsequent cancers of the gastrointestinal tract in the Czech population. Digestive Diseases 2010; 28(4-5): 657-669. Go to original source... Go to PubMed...
  23. Stampach R, Konecny M, Kubicek P, et al. Dynamic cartographic methods for visualization of health statistics. In: Cartography in Central and Eastern Europe. Berlin-Heidelberg: Springer, 2010: 431-442. Go to original source...
  24. Brewer, CA. ColorBrewer - color advice software for cartography. 2014. www.colorbrewe.org. Asssessed May 2014.
  25. ÚZIS. TNM klasifikace zhoubných novotvarů - čtvrté vydání 2. revize 1992. Česká verze, ÚZIS ČR, 1994.
  26. Geryk E, Štampach R, Bajčiová V, kol. Další novotvary u přežívajících do 49 let s gynekologickými nádory. Onkologie 2014; 8(2): 64-71.
  27. Cambell SM, Roland MO. Why do people consult the doctor? Farm Pract 1996; 13: 75-83. Go to original source... Go to PubMed...
  28. Crocetti E, Arniani S, Buiatti E. Synchronous and metachronous diagnosis of multiple primary cancers. Tumori. 1998; 84(1): 9-13. Go to original source... Go to PubMed...
  29. Rabbani F, Reuter VE, Katz J, et al. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology. 2000; 56(3): 399-403. Go to original source... Go to PubMed...
  30. Geryk E, Štampach R, Dítě P, kol. Clinical stages in patients with primary and subsequent cancers based on the Czech Cancer Registry 1976-2005. ISRN Oncology 2013; Article ID 829486, 10 pages, http://dx.doi.org/10.1155/2013/829486. Go to original source... Go to PubMed...
  31. Galper S, Gelman R, Recht A, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2002; 52(2): 406-414. Go to original source... Go to PubMed...
  32. Holland JM, Arsanjani A, Liem BJ, et al. Second malignancies in early stage laryngeal carcinoma patiens treated with radiotherapy. J Laryngol Otol 2002; 116(3): 190-193. Go to original source... Go to PubMed...
  33. Baili P, De Angelis R, Casella I, et al. Italian cancer burden by broad geographical area. Tumori. 2007; 93: 398-407. Go to original source... Go to PubMed...
  34. Gatrell AC, Elliott SJ. Geographies of health: An introduction. Chichester: John Wiley-Sons Ltd, 2009: 1-282.
  35. Boscoe PF, Ward MH, Reynolds P. Current practices in spatial analysis of cancer data: data characteristics and data sources for geographic studies of cancer. Int J Health Geographics 2004; 3: 28-42. Go to original source... Go to PubMed...
  36. Benhamou E, Laplanche A. Estimation de la population ? risque entre deus recensements pour le calcul d'un taux d'incidence ou de mortalité par cancer: comparaison de quatre méthodes. Rev Epidemiol Sante Publ 1991; 39: 71-77.
  37. Nicola Bartolomeo N, Trerotoli P, Serio G. Lung cancer and COPD rates in Apulia: a multilevel multimember model for smoothing disease mapping. Int J Health Geographics 2010; 9: 15-44. Go to original source... Go to PubMed...
  38. Towne SD Jr, Smith ML, Ory MG. Geographic variations in access and utilization of cancer screening services: examining disparities among American Indian and Alaska Native Elders. Int J Health Geographics 2014; 13: 18-43. Go to original source... Go to PubMed...
  39. Beyer KM, Saftlas AF, Anne B Wallis A, et al. A probabilistic sampling method (PSM) for estimating geographic distance to health services when only the region of residence is known. Int J Health Geographics 2011; 10: 4-40. Go to original source... Go to PubMed...
  40. Delamater PL, Messina JP, Shortridge AM, et al. Measuring geographic access to health care: raster and network-based methods. Int J Health Geographics 2012; 11: 15-45. Go to original source... Go to PubMed...
  41. Evans B, Sabel CE. Open-Source Web-based Geographical Information System for health exposure assessment. Int J Health Geographics 2012; 11: 2-38. Go to original source... Go to PubMed...
  42. Coyte A, Morrison DS, McLoone P. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer 2014; 14: 272, www. biomedcentral.com/1471-2407/14/272. Go to original source... Go to PubMed...
  43. Tsukuma H, Fujimoto I, Hanai A, et al. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res. 1994; 85(4): 339-45. Go to original source... Go to PubMed...
  44. Yu GP, Schantz SP, Neugut AI, Zhang ZF. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control. 2006; 17(4): 411-420. Go to original source... Go to PubMed...
  45. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer. 2001; 15(2): 155-161. Go to original source... Go to PubMed...
  46. Heard A, Roder D, Luke C. Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia). Cancer Causes Control. 2005; 16(5): 475-481. Go to original source... Go to PubMed...
  47. American Cancer Society. Multiple primary cancers. Cancer Facts & Figures 2009. Atlanta: American Cancer Society, 2009: 24-41.
  48. VZP. Ročenka Všeobecné zdravotní pojišťovny ČR. Praha: VZP, ediční řada 2010 (s. 68), 2011 (s. 69), 2012 (s. 85), 0, www.vzp.cz.
  49. Maurois A. Dějiny Anglie. Praha: Nakl. Lidové noviny, 1993, 215-216.
  50. www.euractiv.cz.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.